SIG Combibloc Group AG (SIGN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 13.64 |
|---|---|
| 52-week range | 8.00 – 15.81 |
| Return, 1 month / 3 months | +1.3% / −0.8% |
| Return, 1 year / 3 years | +56.0% / −25.9% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 40.7% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 13.18M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SIG Combibloc Group is a packaging company based in Switzerland that makes aseptic carton packs for drinks and liquid foods. It supplies cartons, closures and the filling machines that dairies, juice makers and other food and beverage producers use to pack and preserve their products. The company also provides service and support for its filling equipment. Its customers are mainly food and beverage manufacturers that need long-life packaging for milk, juices, plant-based drinks and similar products.
On this site SIG Combibloc Group AG appears as a stock on the SIX Swiss Exchange (Switzerland), code SIGN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SIG Combibloc Group AG (SIGN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 13.64 on 22 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 60 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 56.0% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.7% | ||
| From 52-week high | -12.3% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | 21.2% | ||
| 12-month return, skipping the last month | 54.0% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 13.18M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | +1.3% |
| 3 months | −0.8% |
| 6 months | +21.2% |
| 1 year | +56.0% |
| 3 years | −25.9% |
| 5 years | −37.8% |
Signals
| 50-day / 200-day average | 13.51 / 12.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Apr 2025 | CHF 0.4900 |
| 26 Apr 2024 | CHF 0.4800 |
| 25 Apr 2023 | CHF 0.4700 |
| 12 Apr 2022 | CHF 0.4500 |
| 26 Apr 2021 | CHF 0.4200 |
| 14 Apr 2020 | CHF 0.3800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.